Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Yuhan
Pharma
ESMO: Should AZ worry about J&J's Tagrisso head-to-head win?
Details from J&J's head-to-head study against AZ's Tagrisso are here. But the debate around EGFR-mutant lung cancer treatment is just beginning.
Angus Liu
Oct 23, 2023 10:30am
Yuhan, Elevar, Hengrui and Astellas—Fierce Pharma Asia
Oct 20, 2023 8:35am
J&J notches Rybrevant trial win as Tagrisso showdown nears
Sep 6, 2023 11:35am
Eisai, Astellas, GSK and more—Fierce Pharma Asia
Jul 21, 2023 8:15am
Sun Pharma, XtalPi, Yuhan—Fierce Pharma Asia
Jun 2, 2023 1:21pm
J&J-Hanmi, BI-Yuhan, GSK and more—FiercePharmaAsia
Jul 12, 2019 11:35am